ATE534654T1 - Mit prostatakrebs in zusammenhang stehende zusammensetzungen, verfahren und kits auf grundlage von dna-makroarray-proteom plattformen - Google Patents
Mit prostatakrebs in zusammenhang stehende zusammensetzungen, verfahren und kits auf grundlage von dna-makroarray-proteom plattformenInfo
- Publication number
- ATE534654T1 ATE534654T1 AT03733941T AT03733941T ATE534654T1 AT E534654 T1 ATE534654 T1 AT E534654T1 AT 03733941 T AT03733941 T AT 03733941T AT 03733941 T AT03733941 T AT 03733941T AT E534654 T1 ATE534654 T1 AT E534654T1
- Authority
- AT
- Austria
- Prior art keywords
- pcadm
- prostate cancer
- dna
- relates
- methods
- Prior art date
Links
- 206010060862 Prostate cancer Diseases 0.000 title abstract 3
- 208000000236 Prostatic Neoplasms Diseases 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title 1
- 230000014509 gene expression Effects 0.000 abstract 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 102000052510 DNA-Binding Proteins Human genes 0.000 abstract 1
- 108700020911 DNA-Binding Proteins Proteins 0.000 abstract 1
- 102000004190 Enzymes Human genes 0.000 abstract 1
- 108090000790 Enzymes Proteins 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 108091034117 Oligonucleotide Proteins 0.000 abstract 1
- 238000003556 assay Methods 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 108020004999 messenger RNA Proteins 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 210000001519 tissue Anatomy 0.000 abstract 1
- 210000004881 tumor cell Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57434—Specifically defined cancers of prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
- C07K2319/23—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a GST-tag
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Urology & Nephrology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Physics & Mathematics (AREA)
- Toxicology (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/140,602 US7790861B2 (en) | 1999-09-24 | 2002-05-07 | Prostate cancer-related compositions, methods, and kits based on DNA macroarray proteomics platforms |
| PCT/US2003/014098 WO2003094844A2 (en) | 2002-05-07 | 2003-05-07 | Prostate cancer-related compositions, methods, and kits based on dna macroarray proteomics platforms |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE534654T1 true ATE534654T1 (de) | 2011-12-15 |
Family
ID=29418388
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03733941T ATE534654T1 (de) | 2002-05-07 | 2003-05-07 | Mit prostatakrebs in zusammenhang stehende zusammensetzungen, verfahren und kits auf grundlage von dna-makroarray-proteom plattformen |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US7790861B2 (enExample) |
| EP (1) | EP1507787B1 (enExample) |
| JP (2) | JP2006518182A (enExample) |
| AT (1) | ATE534654T1 (enExample) |
| AU (1) | AU2003239357B2 (enExample) |
| CA (1) | CA2484845A1 (enExample) |
| RU (1) | RU2004133036A (enExample) |
| WO (1) | WO2003094844A2 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2006292212A1 (en) * | 2005-09-19 | 2007-03-29 | The Johns Hopkins University | Biomarker for prostate cancer |
| JP2007222160A (ja) * | 2006-01-26 | 2007-09-06 | National Institute Of Advanced Industrial & Technology | 生体由来試料中の蛋白質の解析方法 |
| RU2499599C2 (ru) | 2007-09-28 | 2013-11-27 | Интрексон Корпорейшн | Конструкции терапевтического переключения генов и биореакторы для экспрессии биотерапевтических молекул и их применение |
| CN101469348B (zh) * | 2008-08-29 | 2011-07-20 | 苏州福英基因科技有限公司 | 一种前列腺癌症早期的原位杂交检测试剂盒及其检测方法和应用 |
| US10517933B2 (en) | 2015-05-12 | 2019-12-31 | Drexel University | Method of treating androgen receptor negative prostate tumors and their metastases |
| CN108659062B (zh) * | 2018-04-18 | 2021-06-22 | 中国农业科学院兰州畜牧与兽药研究所 | 唾液酸寡糖-磁纳米酶及其制备方法和应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5763209A (en) | 1988-09-26 | 1998-06-09 | Arch Development Corporation | Methods and materials relating to the functional domains of DNA binding proteins |
| US5578444A (en) | 1991-06-27 | 1996-11-26 | Genelabs Technologies, Inc. | Sequence-directed DNA-binding molecules compositions and methods |
| US6066452A (en) | 1997-08-06 | 2000-05-23 | Yale University | Multiplex selection technique for identifying protein-binding sites and DNA-binding proteins |
| US20020042062A1 (en) * | 1999-09-24 | 2002-04-11 | Mark Stearns | Prostate cancer-related compositions, methods, and kits based on DNA macroarray proteomics platforms |
| EP1222307A4 (en) * | 1999-09-24 | 2005-01-26 | Philadelphia Health & Educatio | PCAM-1 MARKING PROTEIN, PCAM-1 ENCODING NUCLEIC ACID SEQUENCES AND PCAM-1 DETECTION IMMUNOASSAY |
| WO2001057190A2 (en) * | 2000-02-03 | 2001-08-09 | Hyseq, Inc. | Novel nucleic acids and polypeptides |
| US6812339B1 (en) * | 2000-09-08 | 2004-11-02 | Applera Corporation | Polymorphisms in known genes associated with human disease, methods of detection and uses thereof |
| WO2005051988A2 (en) * | 2003-03-03 | 2005-06-09 | Genentech, Inc. | Compositions and methods for the treatment of systemic lupus erythematosis |
-
2002
- 2002-05-07 US US10/140,602 patent/US7790861B2/en not_active Expired - Lifetime
-
2003
- 2003-05-05 RU RU2004133036/12A patent/RU2004133036A/ru not_active Application Discontinuation
- 2003-05-07 WO PCT/US2003/014098 patent/WO2003094844A2/en not_active Ceased
- 2003-05-07 JP JP2004502932A patent/JP2006518182A/ja not_active Withdrawn
- 2003-05-07 EP EP20030733941 patent/EP1507787B1/en not_active Expired - Lifetime
- 2003-05-07 CA CA 2484845 patent/CA2484845A1/en not_active Abandoned
- 2003-05-07 AT AT03733941T patent/ATE534654T1/de active
- 2003-05-07 AU AU2003239357A patent/AU2003239357B2/en not_active Ceased
-
2010
- 2010-01-07 JP JP2010001962A patent/JP2010131022A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003094844A3 (en) | 2004-09-10 |
| EP1507787A2 (en) | 2005-02-23 |
| US20030100033A1 (en) | 2003-05-29 |
| EP1507787B1 (en) | 2011-11-23 |
| WO2003094844A2 (en) | 2003-11-20 |
| RU2004133036A (ru) | 2005-06-27 |
| JP2010131022A (ja) | 2010-06-17 |
| JP2006518182A (ja) | 2006-08-10 |
| CA2484845A1 (en) | 2003-11-20 |
| EP1507787A4 (en) | 2006-04-19 |
| US7790861B2 (en) | 2010-09-07 |
| AU2003239357A1 (en) | 2003-11-11 |
| AU2003239357B2 (en) | 2010-05-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Xie et al. | A DNA tetrahedron-based molecular beacon for tumor-related mRNA detection in living cells | |
| Erin et al. | Capsaicin-induced inactivation of sensory neurons promotes a more aggressive gene expression phenotype in breast cancer cells | |
| Nozaki et al. | Cancer cell-derived interleukin 1α contributes to autocrine and paracrine induction of pro-metastatic genes in breast cancer | |
| Reemann et al. | Melanocytes in the skin–comparative whole transcriptome analysis of main skin cell types | |
| WO2004110345A8 (en) | Differentially expressed genes involved in cancer, the polypeptides encoded thereby, and methods of using the same | |
| WO2005100998A3 (en) | Membrane markers for use in cancer diagnosis and therapy | |
| US11401544B2 (en) | Methods of preparing a re-usable single cell and methods for analyzing the epigenome, transcriptome, and genome of a single cell | |
| ATE469968T1 (de) | Verfahren und mittel zur überwachung und modulation des gen-silencing | |
| ATE380195T1 (de) | Zusammensetzungen und verfahren zur behandlung von tumoren | |
| ATE335086T1 (de) | Künstliche chromosomen, die die genetische information für die bildung von rekombinantem virus enthalten | |
| Chang et al. | Determination of high mobility group A1 (HMGA1) expression in hepatocellular carcinoma: a potential prognostic marker | |
| Matjasic et al. | Expression of LOC285758, a potential long non-coding biomarker, is methylation-dependent and correlates with glioma malignancy grade | |
| ATE534654T1 (de) | Mit prostatakrebs in zusammenhang stehende zusammensetzungen, verfahren und kits auf grundlage von dna-makroarray-proteom plattformen | |
| WO2002083081A3 (en) | Prostate cancer-related compositions, methods and kits based on dna macroarray protemics platforms | |
| Nossal et al. | Bacteriophage T4 DNA primase-helicase. Characterization of the DNA synthesis primed by T4 61 protein in the absence of T4 41 protein. | |
| DE69942226D1 (de) | Unterschiedlich exprimierte gene in bauchspeicheldrüsen-krebs und -dysplasie | |
| WO2004033485A3 (en) | Nucleic acid supported protein complementation | |
| Cervantes-Garduño et al. | MT4-MMP modulates the expression of miRNAs in breast cancer cells | |
| Coskunpinar et al. | Identification of a differential expression signature associated with tumorigenesis and metastasis of laryngeal carcinoma | |
| ATE329055T1 (de) | Methode zur erstellung von genexpressionsprofilen | |
| ATE313631T1 (de) | Dna polymerase lambda und ihre verwendungen | |
| DE69632963D1 (de) | Mch3, eine apoptosis-protease, kodierende nukleinsäuren und methoden zur verwendung | |
| Tacheva et al. | Frequency of the common promoter polymorphism MMP2− 1306 C> T in a population from central Bulgaria | |
| DE60123109D1 (de) | Mit schizophrenie in zusammenhang stehendes gen, das für ein potential-abhängiges ionkanal kodiert | |
| WO2005049793A3 (en) | Methods and compositions for combinatorial approaches to cancer gene therapy |